Researchers at Cleveland Clinic Cancer Center are working to better understand the trajectory and risk factors of smoldering multiple myeloma.
Read MoreMP-MRI-US Fusion Targeted Biopsy: A Promising New Diagnostic Tool for Prostate Cancer
Specialized software now combines multiparametric MRI and transrectal ultrasound images to improve targeted biopsy of suspicious lesions. The technology has the potential to significantly improve localization and characterization of prostate cancer when added to a 12-core biopsy.
Blood Biomarkers to Guide Surveillance and Treatment of Uveal Melanoma Being Explored
Discover how Cleveland Clinic physicians are hoping to improve survival in uveal melanoma by identifying patients with micrometastases—and suppressing them before they progress to macrometastases.
Reducing Nausea, Vomiting in Patients With Advanced Cancer
Nausea and vomiting are common in advanced cancer and lead to significant reduction in quality of life. In-depth assessment of each patient and systematic use of several drug classes can reduce the symptoms.
Study Scrutinizes Anticoagulant Use for Cancer Patients
Study finds that not accounting for individual risk factors can lead to mistakes in prescribing anticoagulants, which can increase morbidity and mortality in cancer patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Intraoperative Radiotherapy Has Future For Breast Cancer
For a woman with breast cancer, the prospect of receiving radiation therapy in a single dose during surgery, rather than going through six weeks of radiation treatments, is a welcome one. That possibility is becoming a reality for more women with early-stage breast cancer. Intraoperative radiotherapy (IORT) applies a single dose of radiation directly to … Read More
Probing Extracellular Vesicles’ Role in Cancer and Other Diseases
All cells, including malignant ones, release extracellular vesicles (EV). Since cellular activation or damage enhances EV release, elevated EV levels are biomarkers for such processes. Analyses of circulating EV may provide a noninvasive “molecular snapshot” of tumors or cellular dysfunction, aiding treatment, prognosis estimates and monitoring.
Opto-acoustic Breast Imaging: Can It Reduce the Need for Breast Biopsy?
Cleveland Clinic investigators are helping evaluate a new imaging technology that may better predict which breast masses are cancerous or benign. Opto-acoustic imaging uses hemoglobin concentration and relative oxygenation to differentiate between malignant and nonmalignant lesions.
June Featured Clinical Trials
Learn about featured clinical trials currently enrolling or search our trials database.
Hyperthermic Intraperitoneal Chemotherapy Provides Novel Treatment for Gynecologic Cancers
Hyperthermic intraperitoneal chemotherapy, which involves the intraoperative delivery and circulation of heated cancer drugs, is showing promise for cancers of the peritoneal cavity arising from gynecologic cancers. The technique is a welcome development in the treatment of a disease whose outcome has changed little in the past two decades.
Immunotherapy Shows Promise
Early data from renal cancer dual drug trial reinforces cancer field’s optimism for immunotherapy approaches.